Long-Term Monitoring: An Overview by B. Mesraoua et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
7 
Long-Term Monitoring: An Overview  
B. Mesraoua1, D. Deleu1,2 and H. G. Wieser3  
¹Hamad Hospital, Doha,  
²Weill Cornell Medical College, Doha,  
³University of Zurich, 
1,2Qatar 
3Switzerland 
1. Introduction 
This chapter consists of two parts. In the first part, we will review the indications for long-
term EEG monitoring in the diagnosis and management of epilepsy. This will include the 
differentiation of seizures and epilepsy, appropriate diagnostic and treatment options, the 
techniques and methods used in the EEG monitoring (ambulatory – hospital-based - 
noninvasive and invasive video/EEG telemetry), commercially available monitoring 
systems, and presurgical evaluation of candidates for epilepsy surgery. In the second part, 
we will focus on the continuous EEG monitoring in the Intensive care unit (ICU). In doing 
so, we will describe which ICU patients should undergo continuous EEG (cEEG) 
monitoring; how long such patients should be monitored? We will review the epidemiology 
of nonconvulsive status epilepticus (NCSE) and the pathological EEG patterns commonly 
occurring in the critically ill patient, including NCSE and periodic epileptiform discharges 
(PEDs). We will discuss the methods which enable real time monitoring of seizures, and the 
adequate treatment of these seizures in a timely fashion. We will also discuss the hypothesis 
that progressive brain damage is occurring with NCSE or PEDs and also whether ICU 
patients with “controversial EEG patterns“ should receive aggressive treatment. Finally, we 
discuss the hypothesis that biomarkers, such as neuron- specific enolase (NSE), and 
magnetic resonance imaging (MRI) techniques (diffusion and perfusion MRI) as well as MR-
Spectroscopy, allow to detect the EEG patterns which might result from brain damage or are 
associated with it. 
2. Long-term EEG monitoring in the diagnosis and management of epilepsy 
Long-term Monitoring (LTM) is useful and mandatory in the diagnosis and management of 
epilepsy in epilepsy surgery centers and Intensive care units (ICU). It is used for 
differentiating between epilepsy and paroxysmally occurring  nonepileptic conditions, for 
assessing seizure type and frequency, for diagnosing and treatment of status epilepticus, 
and in noninvasive and invasive video/EEG investigations for epilepsy surgery. The 
Subcommittee of the International League against Epilepsy (ILAE) recommends use of 
hospital-based LTM in these conditions. The management of patients with head trauma, 
stroke, subarachnoid hemorrhage and other cerebrovascular disorders benefit from the 
continuous monitoring of the EEG.  
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Techniques/methods. From the techniques/methods one distinguishes: ambulatory versus 
hospital-based; and noninvasive versus semi-invasive and invasive video/EEG telemetry.  
The ambulatory EEG monitoring uses a small portable EEG recorder which is worn on a 
waist belt. Recording can thereby be made during regular daytime activities and sleep, in the 
natural environment (see Figure 3). The EEG recorder records events that can be reviewed later 
on a special machine in an EEG laboratory. The patient should be asked to keep an account of 
daily activities, so that they can be related to the EEG recordings made at the time.  
In comparison to an inpatient monitoring, ambulatory outpatient monitoring may be less 
informative because: (a) reduction of medication to provoke seizures may not be safe in an 
outpatient, (b) faulty electrode contacts cannot quickly be noticed and repaired, (c) the 
patient may move out of video surveillance, and (d) duration of ambulatory monitoring can 
be limited by technical constraints. 
Video-telemetry uses a video camera linked to an EEG machine. The camera will visually 
record the behavior of the patient, in particular objective signs and symptoms of the seizure,  
and at the same time the EEG machine will record the brainwave pattern. Both the video 
and EEG are stored onto a computer that can be reviewed once the test is finished. The 
consultant will be able to see any episodes/seizures that the patient may have had, as well 
as any changes in the EEG at that time. The test is often carried out over a number of days in 
order to increase the chances of recording habitual and/or all seizure types. Long-term 
video-EEG monitoring is particularly important in the presurgical evaluation of potential 
candidates for surgical epilepsy therapy, and in the ICU. 
Requirements for LTM in general are that it should be suitable for all patient ages, 
including neonates, infants, children, and adults. It should be suitable for hard-to-record 
populations as well, such as children with autism. Superior patient safety is mandatory. The 
user should be able to view all data in standard clinical EEG as well as customizable 
montages. The computer system should allow for data sharing and data archiving. The 
system should use ultra-compact amplifier, integrated software design, digital video 
integration, and world class customer support. Depending on local clinical and research 
needs the integration of specific software for research use, e.g., source estimation software, 
and recordings with 32- to 256-channel (dense array EEG) should be available. 
Requirements for EEG analysis are online methods that can be potentially used for records 
of any duration, with any number of channels, any number of channel groupings (different 
topologies), and in a variety of situations (ICU, sleep, coma, etc.). The system should display 
samples of original EEG that represent the long-term EEG along with their temporal 
distribution. The actual EEG should be presented to the user in a familiar way, so that no 
new interpretive skills are required, i.e., the method can be employed by anyone familiar 
with EEG. An undisputed advantage is a simple graphical display allowing a non-EEG 
specialist to identify abnormal changes, i.e., the emergence of focal changes, bursts or 
sustained asymmetries, gradual or sudden changes, and cycling of EEG patterns. The quick 
identification of problems will allow such personnel to contact the EEG specialist for a 
detailed assessment.  
Commercially available LTM System are equipped with special hardware , software, and 
training items, including an amplifier, acquisition computer, LCD display, net station 
software for EEG acquisition and physician review. In certain conditions a HydroCel 
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Geodesic Sensor Net (HCGSN) may be useful. HCGSN does not require any scalp 
preparation or abrasion and is suitable for all patient ages. Application times for the sponge-
based HCGSN range between 5 minutes for 32 channels to 15 minutes for 256 channels.  
A digital video system is crucial, as is warranty and support. Equally important are on-site 
installation and training visit by a support engineer providing reference materials and 
manuals. Regular training workshops of the staff are usually required and helpful.  
A reviev of  some commercially available Monitoring Systems is given in Table 1. 
 
AirEEG WEE-1000 Nihon Kohden 
Corporation  
The patient wears a transmitter in a pouch 
and an electrode junction box in a shoulder 
strap. The transmitter sends up to 64 channels 
of EEG data to one or more receivers that are 
connected to an electroencephalograph by 
LAN. Wireless is more comfortable.  
Beehive® Horizon 
- Long-term 
Epilepsy 
Monitoring  
Neurotrac® 
Neuromonitoring 
Software  
Grass 
Technologies  
Windows-based digital EEG/Video 
instrument with complete data acquisition, 
recording and review capabilities that are 
specialized for epilepsy monitoring 
applications.  
Neurotrac Neuromonitoring software is 
designed for computing and displaying long-
term trends of EEG features during 
continuous EEG monitoring in the ICU, or 
Seizure Monitoring units. The software 
module can be used with acquisition systems 
configured with any of Grass Technologies’ 
amplifiers. The number of EEG channels 
recorded is dependent on the amplifiers used, 
the electrodes applied to the patient, and the 
selected montage.  
Ceegraph VISION 
EEG  
Ceegraph VISION 
ICU  
Ceegraph VISION 
LTM  
Natus Bio-logic 
Systems  
This system incorporates the latest 
developments in networking, remote 
communications and information 
management.  
Ceegraph VISION is a Windows® XP Pro 
system that can be expanded to integrate all 
EEG needs: epilepsy monitoring, routine EEG, 
ambulatory recordings, and ICU monitoring. 
Ceegraph VISION ICU is designed to 
virtually eliminate the complexities of 
recording and interpreting continuous EEG 
data used to assess neurological status using 
sophisticated EEG analysis software.  
Table 1. Commercially Available Monitoring Systems 
www.intechopen.com
 Epilepsy – Histological, Electroencephalographic and Psychological Aspects 
 
148 
2.1 Diagnostic yield of LTM in the differential diagnosis between epilepsy and 
paroxysmally occurring  nonepileptic conditions 
Events that may cause diagnostic confusion with epilepsy  are (a) Non-epileptic 
pathophysiological events, such as autonomic disorders, cardiac arrhythmias, drug toxicity, 
metabolic disorders, migraine, orthostatic hypotension, sleep disorders, valvular heart 
disease, vasovagal syncope, vestibular disorder, and (b) Non-epileptic psychopathological 
and psychiatric  events, such as anxiety, depression, panic attacks, psychogenic “seizures“ 
and other somatoform disorders, and psychosis. 
Approximately 20% of patients referred to comprehensive epilepsy programs because of 
medically “refractory“ seizures do not have epilepsy. In the study of Benbadis et al [1], 75 
patients (30%) of 251 patients with video EEG monitoring had non-epileptic attacks: 69 
without epilepsy and 6 patients combined with epileptic attacks. 61 patients from the 69 
patients had so-called “psychogenic“ and 8 patients had “other“ attacks. 
Yogarajah et al. [2] studied the value of the ILAE-recommended use of LTM. All admissions 
to the Sir William Gowers Unit at the National Society for Epilepsy (an epilepsy tertiary 
referral unit) in the years 2004 and 2005 were included. In this study LTM was primarily 
responsible for a change in the diagnosis in 133 (58%) and a refinement of diagnosis in 29 
(13%) patients. The most common change was in distinguishing epilepsy from non-epileptic 
attack disorder (NEAD) in 73 (55%) and in distinguishing between focal and generalized 
epilepsy in 47 (35%). LTM was particularly helpful in differentiating frontal lobe seizures 
from generalized seizures and non-epileptic attacks.  
Besides the diagnosis of a seizure disorder and the classification of seizure types, the 
evaluation of precipitating factors  and the quantification of seizures is often very important. 
Surgical localization is another issue and briefly dealt below. 
2.2 LTM in the context of presurgical evaluation of candidates for epilepsy surgery 
LTM in specialized institutions offering epilepsy surgery is often divided into a Phase 1 and 
Phase 2. Phase 1 is noninvasive. In this early stage of examination, three main questions have 
to be answered: (1) Is it epilepsy? (2) What type of epilepsy? And (3) Is it pharmacotherapy 
resistant?  Phase 2 consists of semi-invasive, and invasive techniques to pinpoint the area(s) 
where the seizures originate if pharmacotherapy-resistant epilepsy has been determined. 
Only when a surgically remediable seizure onset zone is determined,then curative epilepsy 
surgery can be considered.  
Epilepsy surgery includes the categories curative (=causal =resective) and palliative epilepsy 
surgery. Curative means resection of the primary epileptogenic zone, i.e. resection of the 
actual and potential seizure onset zone. The goal is postoperative seizure freedom. Types of 
resections include more or less standardized resections as opposed to tailored resections. 
Standardized resections include interventions such as the “selective 
amygdalohippocampectomy” [3-4], anterior temporal lobe resection, and functional 
hemispherectomy (see Figure 1).  
Not infrequently the localization of the seizure onset zone in so-called “eloquent”, i.e. 
indispensable brain area and/or the size of the seizure onset zone prevent its radical 
therapeutic excision. In such a case the “secondary pacemaker areas” (e.g. "ipsilateral 
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discharge amplifiers") may be targeted. For example, in a left posterior neocortical temporal 
lobe epilepsies with rapid propagation of the discharge into the ipsilateral mesial temporal 
structures (-which act then as a secondary pacemaker - ) a so-called “palliative 
hippocampectomy” has sometimes been performed with good results [5]. However, 
palliative interventions usually cannot provide postoperative seizure freedom, but may  
 
Fig. 1. Illustration of types of resective epilepsy surgery showing the MRI after selective 
amygdalohippocampectomy (left), after hemispherectomy (middle portion) and after anterior 
callosal section (right).  
 
 
 
 
Fig. 2. Illustration of the conceptual zones of the “epileptic“ focus. The lesional zone is 
characterized by the anatomical, i.e. morphological lesion; the irritative zone by the territory 
exhibiting “interictal spiking“. The functional deficit zone is characterized by neurological 
and/or neuropsychological deficits and/or functional imaging (PET,SPECT) abnormalities; 
the symptomatogenic zone, by the “primictal“, i.e. very early, ictal signs and symptoms. 
Depending whether the patient is rendered seizure-free or not after surgical excision, the 
seizure onset zone can be further divided into an actual and potential seizure onset zone.  
www.intechopen.com
 Epilepsy – Histological, Electroencephalographic and Psychological Aspects 
 
150 
ameliorate the patient`s seizure situation. Palliative procedures include callosal section (i.e., 
corpus callosum section, CCS; including Gamma Knife CCT), vagal nerve stimulation (VNS) 
and deep brain stimulation (DBS).  
Curative epilepsy surgery relies on the concept of the "epileptic focus". At least for practical 
purposes, the “focus”- concept is still valuable, although the network hypothesis might be 
more realistic. Using stereo-electroencephalography (SEEG)  Talairach and Bancaud have 
described a “zone lésionelle“, a “zone irritative“, and a “zone épileptogène“ [6]. Wieser [7-8]  
and Lüders [9] enlarged the focus concept to the following zones (1) lesional (2) primary 
epileptogenic, (3) secondary epileptogenic (including the "mirror focus", and the "ipsilateral 
discharge amplifier"), (4) irritative, (5) functional deficit, and (6) symptomatogenic. Lüders et al. 
[10] then divided the epileptogenic zone into the (a) actual, and (b) potential seizure onset 
zones, depending whether the patient is rendered seizure-free or not after surgical excision. 
It is very important to note that the seizure onset zone is not identical with the lesion. Often 
it is in the vicinity of a lesion, but can be located in or involve remote areas [Figure 2]. 
Long-term video-EEG monitoring can be performed using conventional scalp electrodes, "true 
temporal electrodes", sphenoidal electrodes, and in the context of presurgical evaluation the 
so-called semi-invasive and invasive techniques. Foramen ovale (FO) electrodes are semi-invasive 
[11]. The so-called invasive techniques include stereo-electroencephalography [12] and subdural 
strip- and grid electrodes. Not infrequently non-invasive, semi-invasive and invasive 
techniques are combined with the goal to optimize the diagnostic yield in an individual 
patient. [8-9,13-14].  
Figures 3 to 6 illustrate some aspects of LTM in the context of presurgical evaluation of 
candidates for epilepsy surgery. Figures 7 to 9 some research aspect, for example the question 
 
Fig. 3. Placement of a subdural grid during intraoperative electrocorticography (left) and 
illustration of stereoelectroencephalography (SEEG , middle portion) with a combined scalp- 
and depth-EEG recorded periamygdalar left seizure discharge, not seen in the scalp EEG. 
The positioning of the 7 depth electrodes (indicated by large and bold numbers) is indicated 
in the brain map. Each depth electrode has 10 contacts numbered 1 to 10 from inside to 
outside (small numbers). At the right ambulatory SEEG monitoring is illustrated (University 
Hospital Zurich 1984).  
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of spike activation and seizure precipitation associated with different sleep stages (Figure 
8) and seizure prediction (Figure 9). For the latter the pre-ictal spike frequency, the surface 
negative DC-shift, the inter- and intrahemispheric coupling strength , and some indicators 
derived from the "chaos theory" (e.g. Lyapunov-exponents and correlation dimension) 
have been examined. Figure 9 is an example that nonlinear time-series analysis with 
neuronal complexity loss in interictal EEG recorded with foramen ovale electrodes can 
predict a seizure. However, in the illustrated case the calculation was done off-line [15-
16]. 
 
Fig. 4. llustration of invasive video-SEEG monitoring in a patient with pharmaco-
resistant temporal lobe epilepsy. Depicted is an example of electroclinical seizure 
analysis: During the right hippocampal high-frequency “tonic“ seizure discharge (of 8 
seconds, channel 29; the discharge starts at 01:33:14, see left top video-picture) the drowsy 
patient experienced an olfactory-gustatory aura with ipsilateral nose wiping (modified 
from Wieser 1983 [7] ). 
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Fig. 5. CT (left) and x-rays with lateral (middle portion) and ap view (right) showing the 
position of the foramen ovale (FO) electrodes with 10 contacts. Contact 1 is in the ambient 
cistern and contact 10 close to the foramen ovale.  
 
  
Fig. 6. Illustration of a foramen ovale (FO) recorded right mesiotemporal seizure. Note that 
the conventional scalp EEG does not reliably pick up this seizure discharge. A total of 12 
seconds are shown towards the end of this seizure. Recording from the 10-contact FO 
electrodes is in a closed chain starting with contact 1 of the right FO electrode (RFO1). R, 
right; L left. 
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Fig. 7. Top: Example of LTM during an intermittent left hemispheric status epilepticus, 
showing the actual EEG with seizure discharges of 1.5 - 4 min and intervals of 5 -14 minutes. 
Bottom left: Graphical display of compressed spectral array over 3 hours (05.00 to 08.00 a.m) 
showing 4 seizure dicharges in the depth EEG recording from right amygdala. The arrow 
indicates the spectral edge frequency (SEF) marker set at 97%. Measurement time is 120 
msec, power range is -20 to -60d. Frequency is from 0 to 32 Hz. Bottom right: Example of the 
summary display of a surface EEG-LTM (18:05 to 09:45) using the automatic seizure 
detection Grass-Telefactor TWin 2.60 software. The patient had numerous subclinical 
seizure discharges (indicated by green bars) and one clinical seizure (indicated by the 
yellow bar; the circle denotes alarm button press). Quantification of seizure discharges 
during the black vertical bars revealed more than 20 discharges/hour. 
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Fig. 8. Chrono-spectrogramm (illustrated are 45 minutes), depicting the vigilance-related  
activation of spikes using an automatic spike detection algorithm and power in band (BIP) 4-6 
Hz (indicating superficial SWS-sleep). Illustrated are the results of two foramen ovale 
channels, one right (RFO) and one left (LFO). At the right of the figure a display of quantified 
FO electrode recorded spikes is shown. There is a marked left anterior mesiotemporal 
preponderance of spiking. Spiking (measured in units from 0 to 10) is activated during 
superficial slow-wave-sleep with increase of theta waves (PIB 4-6 Hz is measured in units 0 to 5).  
 
Fig. 9. Seizure prediction: Plot of the correlation dimension D2 over 30 minutes indicating 
that this measure predicted a seizure about 3 minutes before onset of the foramen ovale 
recorded seizure discharge. Beginning of the seizure is at the vertical line (b). The D2 
transgresses a critical treshold at the vertical line (a). (See also [15 and 16]).  
2.3 LTM in the diagnosis and treatment of status epilepticus 
Continuous EEG (cEEG ) monitoring of critically ill patients is frequently utilized to detect 
non-convulsive seizures (NCS) and non-convulsive status epilepticus (NCSE). Abend et al. 
[17] studied  the current practice of cEEG in critically ill patients. The authors conducted an 
international survey of neurologists focused on cEEG utilization and NCS management:  
83% of 330 physicians who completed the survey used cEEG at least once per month and 
86% managed NCS at least five times per year. The use of cEEG in patients with altered 
mental status was common (69%), with higher use if the patient had a prior convulsion 
(89%) or abnormal eye movements (85%). Most respondents would continue cEEG for 24 h. 
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If NCS or NCSE was identified, the most common anticonvulsants administered were 
phenytoin/fosphenytoin, lorazepam, or levetiracetam, with slightly more use of 
levetiracetam for NCS than NCSE. 
3. Continuous EEG monitoring in the Intensive Care Unit  
In the ICUs, cEEG monitoring reveals the presence of electrographic seizures in a significant 
percentage of critically ill patients and in patients with depressed levels of consciousness 
[18-29]. cEEG monitoring is primarily conducted to detect epileptic seizures. It helps 
assessing the long-term EEG trends and the level of sedation; both essential for treatment 
and prognosis. Another argument to perform cEEG monitoring in the ICU is cost-
containment: In a retrospective study of refractory status epilepticus (RSE) following NCSE 
(RSE defined as seizures lasting more than 60 minutes and failure of two AEDs), Mayer et 
al. [30] concluded that it is imperative to diagnose and treat NCS/NCSE as early as possible 
since the prognosis worsens with increasing duration of seizures which will prolong these 
patients stay in the ICU and consequently increase the cost on health care ressources. 
3.1 ICU patients that should undergo cEEG monitoring 
NCSE is usually diagnosed when facing a patient with an abnormal mental status and 
diminished responsiveness, a “compatible“ EEG, and frequently a clinical  response to 
antiepileptic therapy. Kaplan [27] asks for both, an alteration in the level of consciousness 
for 30 to 60 minutes and some seizure activity in the EEG to diagnose NCSE. The EEG 
remains the most important tool to diagnose NCSE. NCSE can be found in different patient 
populations, for example in psychiatric and mentally retarded patients on psychotropic 
medications, and in patients with a history of epilepsy after a tonic–clonic seizure. 
NCSE/NCSs are common in critically ill patients [19,21]. Therefore, we believe that ICU 
patients with impaired consciousness, especially those patients with unclear etiology, 
should undergo cEEG monitoring. Clinical conditions where it is appropriate to look for 
NCSE, are: (a) unexplained diminished level of consciousness (with or without limb and 
facial twitching and/or eye deviation) in the ICU; (b) confusional states or altered mental 
status in patients in the emergency room [31]; (c) patients with persisting lethargy or 
behavioral changes after a tonic-clonic seizure [32], (d) psychomotor retardation or 
behavioral changes beyong baseline in a psychiatric or mentally retarded patient;  
 
 Lethargy and confusion attributed to a postictal state 
 Ictal confusion mistaken for metabolic encephalopathy 
 Unresponsiveness and catalepsy presumed to be psychogenic 
 Obtundation thought to be due to alcohol or drug intoxication 
 Hallucinations and agitation mistaken for psychosis or delirium 
 Lethargy presumed secondary to hypoglycemia 
 Mutism attributed to aphasia 
 Laughing and crying ascribed to emotional lability 
Table 2. Clinical examples in which the diagnosis of NCSE was missed or delayed 
Reproduced from Kaplan PW. Behavioral manifestations of nonconvulsive status 
epilepticus. Epilepsy and Behavior 2002; 3:122-139 
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(e) comatose patients with metabolic / infectious or toxic problems in the ICU [23]; (f) ICU 
patients in coma with known epilepsy, aged <18 years, with a history of convulsive seizures 
[22]; (g) patients with alteration of level of consciousness after Benzodiazepine withdrawal 
[33]; (f) patients with drug-induced confusional states such as lithium [34], tiagabine [35] or 
ifosfamide [36]. Table 2 lists clinical examples in which the diagnosis of NCSE was missed or 
delayed. 
3.2 Epidemiology of NCSE  
There have been no large-scale population-based studies regarding selectively NCSE. 
Dunnes et al. [37] estimate that NCSE constitutes 20% of all status epilepticus in adults. 
Recent populations-based studies have reported a higher percentage of NCSE among all 
status epilepticus (30% to 60%) [38-42]. This wide range is explained by the difference in 
NCSE definition, classification and  probably the differences in population characteristics. 
Knake et al. [40] reported the highest proportion of NCSE in the adult population. Both the 
large number of patients over 65 years, and the history of stroke and epilepsy might explain 
this unusually elevated percentage of NCSE in this study. Shorvon [43] reports an annual 
incidence of NCSE ranging from 5 to 11 per 100,000. Shorvon`s figures are likely 
underestimates because of the challenges in diagnosing NCSE and also the need for 
continuous EEG monitoring.  
3.3 Duration of monitoring in the ICU 
There is still no general rule on how long cEEG monitoring should be performed to 
efficiently detect seizures. Claassen et al. [19] looked for NCSE in comatose patients: in 13% 
of these patients, the seizures were recorded during the third day. Unless seizures are 
recorded during the first few hours, or there is strong suspicion for seizures occurence based 
on the clinical manifestations and the EEG  data or both, we usually record for 24 hours; one 
example are the periodic discharges (PD). Claassen et al. [19] have shown that the occurence of 
PD during EEG monitoring is a risk factor for seizures and,  in such cases , recording might 
go beyond 48 hours. Once the seizures are detected and treatment started, EEG monitoring 
should run uninterrupted from the time continuous IV AEDs is started, until the patient is 
successfully treated. Frequency of further EEG monitoring depends on the patient’s 
condition; less often EEG recording may be sufficient if the seizures are stopped, while 
persistent or recurrent seizures require more intensive monitoring. 
3.4 Pathological EEG patterns commonly occurring in the critically ill patient 
A large spectrum of ictal EEG abnormalities may be seen in the ICU, particularly with NCSE 
[45-46]: Periodic short-interval diffuse discharges (PSIDD) are usually seen in  anoxia, metabolic  
encephalopathy, Creutzfeldt Jakob disease, and toxic encephalopathy (lithium and  
baclofen). Periodic long-interval diffuse discharges (PLIDD), also called Radermecker 
complexes, are seen in patients suffering from Subacute Sclerosing Panencephalitis (SSPE) 
and in patients with Phencyclidine (“angel dust”) or ketamine intoxication [47-51]. PLIDD-
like patterns are also seen in anoxia and  barbiturate intoxication.  
The following benign electroencephalographic variants and patterns of uncertain significance may 
appear during cEEG monitoring but have to be separated from the  EEG findings described 
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above [47,52]. These patterns include: “Rhythmic temporal Theta bursts of drowsiness 
[psychomotor variant]”, “Midline theta rhythms [formerly Ciganek-rhythm]”, “Subclinical rhythmic 
electrographic discharge in adults [SREDA]”, “Wicket spikes”, “Small sharp spikes [SSS- previously 
called  Benign epileptiform transients of sleep [BETS]”, “14 and 6 Hz positive bursts” and “6 Hz 
spike and wave [also called Phantom spike and wave]” . 
Generalized periodic burst suppression, generalized periodic slow-wave complexes (GPSC), 
generalized repetitive sharp transients , and generalized periodic triphasic waves are seen in 
patients with anoxic/metabolic encephalopathies. GPSC may also occur in subacute 
sclerosing panencephalitis and in other encephalitis. In comatose patients after 
cardiorespiratory arrest, burst suppression usually indicates a poor  outcome.  
Other EEG patterns that are often seen in the ICU are classified according to their   
predominant  EEG frequencies, their morphology or distribution [52]. The following 
patterns involve mainly the alpha frequencies: Alpha squeak, retained alpha [53], alpha 
delta sleep [54], unilateral decrease in reactivity of alpha activity and  extreme spindles. Beta 
frequencies include the fast alpha variant,  posterior temporal fast activity in children, fast 
spiky spindle variant, central fast activity, and diffuse paroxysmal or continuous fast 
activity.The theta frequencies comprise slow alpha variant, frontal arousal rhythm, rhythmic 
temporal theta activity of drowsiness, middle theta rhythms, and focal parietal theta 
activity.The delta frequencies include the transient rhythmic slowing occurring after eye 
closure and more continuous posterior rhythmic slowing . Claassen et al. [19]  summarized 
some EEG patterns seen in the critically ill ICU patient [Table 3] 
 
Electrographic seizures Rhythmic discharge or spike and wave pattern with 
definite evolution in frequency, location or morphology, 
lasting at least 10s; evolution in amplitude alone does not 
qualify 
Periodic epileptiform 
discharges (PEDs) 
Repetitive sharp waves, spikes, or sharply contoured waves 
at regular or nearly regular intervals and without clear 
evolution in frequency or location (includes, PLEDs, 
GPEDs, BiPLEDs, triphasic waves) 
Periodic lateralized 
epileptiform discharges 
(PLEDs) 
Consistently lateralized PEDs 
Generalized PEDs 
(GPEDs) 
Bilateral and synchronous PEDs with no consistent 
lateralization 
Bilateral PLEDs (BiPLEDs) PLEDs occurring bilaterally, but independently and 
asynchronously 
Triphasic waves Generalized periodic sharp waves or sharply contoured 
delta waves with triphasic morphology at 1-3 Hz 
with/without anterior-posterior or posterior-anterior lag 
Frontal intermittent 
rhythmic delta activity 
(FIRDA) 
Moderate to high voltage monorhythmic and sinusoidal 1-
rhythmic delta 3 Hz activity seen bilaterally maximal in 
anterior leads, no evolution 
Table 3. Definitions of EEG patterns in ICU seizures given by Claassen [19] 
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3.5 Controversial EEG patterns  
NCSE  is accompanied with EEG patterns that are often seen with clinical seizures; however 
many EEG patterns are called “controversial“, because the question whether they are ictal in 
nature or not, is still debated.  
3.6 Periodic patterns 
These  include periodic epileptiform discharges (PEDs) which can be generalized (GPEDs) 
or lateralized (periodic lateralized epileptiform discharges, PLEDs); or bilateral independent 
periodic epileptiform discharges (BIPLEDs). 
PLEDs are lateralized complexes made up of sharp waves or spikes possibly followed by a 
slow wave and recurring every one to two seconds [55]. PLEDs are often associated with 
clinical seizures and also with destructive hemispherical lesions [56]. A great proportion of 
ICU patients showing these patterns present clinical/electrographic seizures during EEG 
monitoring [57]. Treiman et al. [58] reported  a sequence of five EEG patterns of ictal 
discharges observed during an untreated generalized convulsive status epilepticus: discrete 
electrographic seizures, waxing and waning, continuous with flat periods, and PLEDs on a 
relatively flat background. According to Garzon et al. [59] these patterns should be 
considered as ictal when they evolve from lower to faster rates(>2 Hz), change their 
frequencies, morphology or field (PLEDs-plus). PLEDs are shown in Figure 10.  
BIPLEDs are less common than PLEDs; the complexes are asynchronous; their morphology, 
amplitude, frequency and location generally differ from one hemisphere to the other. They  
 
Fig. 10. Periodic lateralized epileptiform discharges (PLEDs) in a 64-year old woman with a 
right frontal astrocytoma. PLEDs display 1,5 Hz with intervening fast frequencies (PLEDs-
plus). PLEDs-plus is extremely likely to evolve into electrographic seizures; whether this 
pattern represents nonconvulsive status epilepticus is debated.  
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are found in hypoxic encephalopathy, encephalitis/meningitis and chronic seizure 
disorders [60-62]. BIPLEDs are shown in Figure 11.  
GPEDs [Figure 12]  occur in anoxic-ischemic coma, Creutzfeld-Jacob disease, metabolic 
encephalopathies, CNS infections such as SSPE, HSV, and in  final stages of status 
epilepticus. GPEDs may represent NCSE [63] or an epileptic encephalopathy [64-65]. 
 
Fig. 11. This EEG shows bilateral independent peudoperiodic lateralized epileptiform 
discharges in an obtunded patient with left hemisphere complexes every several seconds, 
independent from right-sided discharges.  
4. Triphasic waves (TWs)   
In NCSE/NCSs, Kaplan [66] describes the TWs as follows: Surface-negative, blunted 
triphasic complexes with  (a) low amplitude, blunted, negative first phase (often wide-
based); (b) dominant, steep positive second phase, and (c) slow rising third slow-wave 
component. No polyspike component. Complex duration: 400-600 msec; amplitude: 100 to 
300 uV on referential montage; smaller on bipolar. Frequency: 1.0-2.5 Hz (typically 1.8 Hz); 
persistence: wax and wane, but more than 10% of a standard recording (20 min). 
Evolution/reactivity: decrease in sleep, drowsiness or after BZPs; increase and reappear 
with arousal or noxious stimulation. May exhibit phase-lag best seen on referential montage. 
TWs may present an epileptiform morphology with spike-like ongoing first phases, and 
spike-slow-wave complexes. In such cases, it is not easy to differentiate NCSE from 
metabolic encephalopathy, particularly when TWs run at a frequency exceeding 1 per 
second. Hence there exist the terms triphasic-like waves and nonepileptic true TWs [63]. 
Indeed, in NCSE, TWS and generalized spike-wave discharges look  similar. In metabolic 
encephalopathies, in Creutzfeld-Jacob disease, and in the course of status epilepticus, 
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bisynchronous periodic sharp complexes with a triphasic configuration are frequently found 
[58,67-69]. The generalized periodic patterns, associated  with  lithium, baclofen, ifosfamide, 
metrizamide, tiagabine, and levodopa, might represent NCSE [70-75]. TWs are also reported 
in Alzheimer disease [76]. TWs are shown in Figure 13 and “ Epileptiform triphasic waves“ 
in Figure 14. 
 
Fig. 12. Generalized periodic epileptiform discharges (GPEDs) in a 45-year-old-man  
 
 
Fig. 13. Triphasic waves in a 51-year-old man with hepatic failure. 
SIRPIDs. Stimuli-induced rhythmic periodic, or ictal discharges [SIRPIDs] were first described by 
Hirsch et al [77]. These are periodic discharges, focal or generalized, frequently seen 
immediately after  stimulation or arousal of a comatose or stuporous patient. SIRPIDs occur  
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with acute brain disorders (brain injury) and severe metabolic disorders. Is not clear 
whether SIRPIDs represent reflex seizures, abnormal arousal patterns, or a combination of 
both. It has been speculated that faster discharges (more than 3Hz) may be ictal, whereas the 
slower ones are less likely to be ictal. Few patients have clinical correlates to their SIRPIDs. 
SIRPIDs are shown in Figure 15. 
4.1 Nonconvulsive status epilepticus in the critically ill ICU patient 
There exists a large literature dealing with classification and electroclinical accompaniments 
of nonconvulsive status epilepticus (NCSE). NCSE is a heterogenous condition. Its diagnosis 
is difficult on the basis of clinical semiology alone. An impaired mental status, a reduced 
responsiveness, a supportive EEG and a response to antiepileptic medications are important 
criteria to diagnose NCSE. A continuous EEG ictal activity and impaired consciousness for 
one hour are necessary according to Tomson et al [78]; some form of EEG seizure activity 
and an impaired consciousness for 30 to 60 minutes according to Kaplan [27]. Because NCSE 
is not accompanied by generalized jerky movements, cEEG monitoring  is essential for 
detecting nonconvulsive seizures (NCSs)/ NCSE  particularly in the ICU [21-29,79]. EEG 
characteristics of NCSs/NCSE are heterogeneous, with a highly variable morphology; Table 
4 describes the EEG patterns occuring in NCSE [25] . 
 
 
Fig. 14. Epileptiform triphasic waves  
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Of particular interest is the distinction between NCSE (as described above) and an epileptic 
encephalopathy [80]. In this later condition, the impaired level of consciousness is related to 
the underlying brain pathology causing the seizures rather than the seizures themselves 
[22,79,81-83].  
Although nonconvulsive seizures and NCSE are common in the critically ill patient, many 
neurologists may be challenged by the frequent “absence“ of specific clinical  signs, and the 
difficulty in interpreting the EEG when confronted to such patients. A trial of rapid acting 
benzodiazepine might be helpful.  
Not infrequently NCSE follows a convulsive status epilepticus [32]. In the study of 
DeLorenzo et al [32], using cEEG recording after the control of convulsive status epilepticus, 
in 164 patients, the authors found that 48% showed persistent electrographic seizures, with 
NCSE in 14% of them. The authors concluded that the use of  cEEG monitoring in these 
patients was essential in detecting NCSE. Figure 16 shows an example of NCSE.  
 
 
 
Fig. 15. Stimulus-induced rhythmic periodic or ictal discharges (SIRPIDs). Repetitive 
right-hemispheric spikes at 2 Hz were provoked by sternal rub in a patient with 
subarachnoid hemorrhage.There is simultaneous semi-rhythmic delta activity over the left 
hemisphere. Electromyographic artifacts indicate a probable change in the patient’s state 
of alertness.  
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In patients without a known epileptic encephalopathy 
1. Repetitive generalized or focal spikes, poly-spike, sharp waves, spike–and-wave or 
Spike-and-slow wave complexes at > 2.5/second. 
2. Above with discharges < 2.5/second but with EEG and clinical improvement after 
rapid onset anti-epileptic drugs, typically benzodazepines (BZPs). [Testing for 
patient responsiveness and improvement in EEG!  EEG: Increases in EEG reactivity 
and appearance of EEG background activity]. 
3. Above, with discharges < 2.5/second with focal ictal phenomena (e.g. facial 
twitching, nystagmus, limb myoclonus). 
4. Rhythmic waves (theta-delta) at >0.5 Hz with (a) incrementing onset (increase in 
voltage with increase or decrease in frequency), (b) evolution in pattern (increase or 
decrease in frequency (>1Hz), or location [changes in discharge voltage (amplitude) 
or morphology are not sufficient], or (c) decrementing termination (voltage or 
frequency), (d) post-PEDs background slowing or attenuation. (a), (b), (c) or (d) may 
be acutely induced by IV BZPs. 
 
In patients with known epileptic encephalopathy 
1. Frequent or continuous generalized spike-wave discharges which show an increase 
in profusion or frequency when compared to baseline EEG with observable change 
in clinical state 
2. Regression (improvement) of clinical or EEG features with BZPs. 
Caveat: these are working definitions, exceptions may occur. This classification is not a rote 
endorsement of the use of parenteral BZPs, which carry clear risk of hypotension and hypopnea. 
(Classification modified from Kaplan 2005; Young et al. 1996; Hirsh et al. 2005). From Kaplan PW. EEG 
criteria for nonconvulsive status epilepticus. Epilepsia. 2007; 48 Suppl 8:39-41.  
Table 4. EEG patterns suggestive of Nonconvulsive status epilepticus 
4.2 Do NCSE or some EEG patterns (PEDs) damage the brain ? 
PLEDs are often seen with destructive hemispherical lesions and associated with clinical 
seizures. Baroque & Purdy assessed 32 patients who had undergone computed tomography 
(CT) and/or magnetic resonance imaging (MRI). PLEDs and BIPLEDs correlated with 
postmortem data that showed consistent localization of lesions in the gray matter [56]. 
Investigators using serial EEG, SPECT, and FDG-positron emission tomography (PET) 
findings argue that PEDs following SE are often ictal [84]. Others classify PEDs as postictal 
or simply as markers (an epiphenomenon) of severe injury or encephalopathy. In several 
studies PLEDS were associated with refractory SE [49]. Jaitly et al [85] reported that ictal 
discharges which follow GCSE may be harmful. Indeed these discharges are associated with 
an increase in morbidity and mortality [85]. The mortality in NCSE is similar to that of 
GCSE. Seizures duration and delay in diagnosis were the factors which correlated the most 
with mortality rate (33%) [86]. Claassen et al. [87] reported even a higher mortality rate 
(75%) when NCSE was the first clinical presentation. NCSE could cause long term sequelae 
from neuronal injury , e.g., impaired cognition or memory loss might result from cortical or 
hippocampal injury [88]. 
As mentioned above, NCSE following generalized convulsive status epilepticus is often a 
refractory status epilepticus and carries a high mortality [32]. Therefore, it is imperative to 
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diagnose and treat patients with this condition as early as possible because the prognosis 
worsens with increasing duration of seizure activity, inducing then more complications and 
ending  with high morbidity and mortality.  
 
Fig. 16. Nonconvulsive status epilepticus (NCSE) evolving from left-hemisphere periodic 
lateralized epileptiform discharges (PLEDs) in a 66-year-old man with a left frontal 
intracerebral hemorrhage. Initially the EEG shows periodic discharges at 1,5 per second, 
which are invariant for several minutes, then gradually increase in frequency and merge to 
electrographic theta activity over the entire left hemisphere.This pattern repeated every 5 to 
10 minutes for several hours.  
There is a strong evidence that the marker of neuronal injury, neuron-specific enolase (NSE) is 
elevated during NCSE [89-91]. In these studies the level of NSE correlated with the duration 
of SE favorizing an early treatment of NCSE.  
Autopsies of patients with NCSE have shown focal neuronal loss. Three patients, who  died 
11 to 27 days after the onset of focal motor status epilepticus, but without pre-existing 
epilepsy, showed neuronal loss and gliosis in the hippocampus, amygdala and 
periamygdalar area, dorsomedial thalamus, Purkinje cells, pirifrom and entorhinal cortices 
[92]. The neuronal injury might be responsible for the seizures and NCSE recurrence [93].  
In accordance with autopsy studies, nonspecific CT and MRI findings have been reported in 
NCSE. For example, MRI has shown a transient increased signal in the hippocampus after 
NCSE [94]. In NCSE, FDG-PET changes are not very consistent, but one reported case 
showed a focal hypermetabolism which corresponded to the localization of EEG seizure 
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activity [95]. The use of SPECT during the seizures (”ictal SPECT”) is easier and helpful in 
localizing the epileptic focus [96]. 
In humans, the underlying pathophysiology of the various subtypes of NCSE has not 
been investigated in detail [97-98]. The correlation with underlying pathology, EEG 
patterns, type of treatment and prognosis remains to be studied. Valid data regarding 
which EEG patterns cause ongoing neuronal damage are still lacking. Therefore we do not 
know which patient suffering from  NCSE should be treated aggressively. Subtle cases of 
NCSE may resolve spontaneously. Patients with NCSE with minimal obtundation have a 
morbidity and mortality of 7%, whereas those with deep lethargy or coma have a 
mortality rate of 39%. [86]. Whereas Treiman [99] explicitly recommends that a patient 
actively having seizures or being comatose and who exhibits any of the periodic 
epileptiform discharge patterns on EEG should be treated aggressively to stop all clinical 
and electrical seizure activity to prevent further neurological morbidity and mortality, 
Kaplan [100] believes that aggressive ICU management of NCSE in the elderly critically ill 
patient may be harmful rather than beneficial . 
4.3 Future study: To develop a novel cEEG monitoring system able to monitor 
seizures in real time, and adequately treat these seizures in a timely fashion 
Available seizure-detection software algorithms are geared  towards patients  with normal 
EEG backgrounds and high-frequency rhythmic seizure discharges. Unfortunately these 
computer algorithms are not very successful to detect NCSs/NCSE in ICU patients. This 
because (a) these kind of seizures have a tendency to wax and wane and do evolve more 
slowly when compared to the fast activity seen in convulsive seizures, and (b) these seizures  
are harder to separate from the abnormal background activity related to the impaired 
vigilance and the associated metabolic disturbances often found in ICU patients [45].  
In an ongoing study (Mesraoua et al; see also [101]) we are planning  to develop a novel 
cEEG monitoring system to be used in the ICU. This system should be able to detect 
pathological EEG patterns commonly occurring in the critically ill patient (NCSE and PEDs, 
TWs). This system should also be able to quantify the frequency and duration of seizures 
and will make possible an adequate antiepileptic drug (AED) treatment, in a timely fashion, 
using the recommended antiepileptic drugs in nonconvulsive seizures/NCSE [102-108]. 
Using the available neuroradiologic tools (MRIs, MRS) and the CNS biomarkers (Neuron-
specific Enolase , NSE), we will examine  the possibility that brain damage is occuring with 
NCSE or PEDs. This way we hope to answer the most important question, i.e., whether 
NCSE and PEDs should be treated aggressively. This study is a combined effort between 
neuroscientists/neurologists and signal processing specialists in order to develop a software 
for the cEEG. The technique will use wavelet transforms (WTs) and wavelet packet energy ratio 
(WPER) which have been proven to be successful tools for epileptic seizure detection, 
particularly in temporal lobe epilepsy [109-100]. The proposed seizure detection algorithm 
will perform the following: 
1. Subdivide the EEG signal into segments for individual interpretation, 
2. Extract features which characterize the individual segments based on EEG behavior in 
the ICU, 
3. Identify the onset of seizures, specifically NCS and NCSE seizures, using the extracted 
features,  
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4. Identify the offset of a seizure, and 
5. Provide summaries of the seizure activity over the monitored time frame. 
This 3-year research study has just started and no conclusion can be drawn at the present 
time. Hopefully, cEEG monitoring with the developed algorithm will be able to identify 
NCSs/NCSE in critically ill patients and thus will help to improve treatment protocols to 
prevent morbidity.  
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